Skip to main content

QVT Financial LP

SEC CIK
0001290162
Latest filing
Aug 14, 2026

The latest 13F from QVT Financial LP covers Q2 2026 (filed Aug 14, 2026): 72 long positions worth $1.56B. The top 10 holdings make up 80.1% of the portfolio, and the largest is Roivant Sciences Ltd. (ROIV) at 53.7%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
14
Est. +$36.6M
Added
13
Est. +$107.3M
Reduced
23
Est. −$101.3M
Sold out
9
Est. −$31.4M

Top 5 holdings

Share of this quarter's portfolio value

  1. ROIVRoivant Sciences Ltd.
    53.7%$839.6MHistory
  2. SPYSPDR S&P 500 ETF Trust
    4.6%$71.6MHistory
  3. ECOOkeanis Eco Tankers Corp.
    4.1%$64.2MHistory
  4. ALLTAllot Ltd.
    3.2%$49.5MHistory
  5. GSGoldman Sachs Group Inc
    3.1%$48.8MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. SPYSPDR S&P 500 ETF Trust
    +$68.1MAddedHistory
  2. Vishay Intertechnology Inc928298AR9
    +$12.9MNew
  3. BRK.BBerkshire Hathaway Inc
    +$9.60MAddedHistory
  4. NXSTNexstar Media Group, Inc.
    +$7.79MAddedHistory
  5. Nuvation Bio Inc.67080NAA9
    +$7.30MNew

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. SPYSPDR S&P 500 ETF Trust
    +4.34 pp0.2% → 4.6%History
  2. Vishay Intertechnology Inc928298AR9
    +0.83 pp0.0% → 0.8%
  3. MGNIMagnite, Inc.
    +0.48 pp0.4% → 0.9%History
  4. Nuvation Bio Inc.67080NAA9
    +0.47 pp0.0% → 0.5%
  5. RDCMRadcom Ltd
    +0.40 pp0.0% → 0.4%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ROIVRoivant Sciences Ltd.
    −$50.9MReducedHistory
  2. ATEXAnterix Inc.
    −$12.4MReducedHistory
  3. FOLDAmicus Therapeutics, Inc.
    −$10.1MSold outHistory
  4. BIRKBirkenstock Holding plc
    −$9.80MSold outHistory
  5. GSGoldman Sachs Group Inc
    −$8.11MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. ROIVRoivant Sciences Ltd.
    −1.32 pp55.1% → 53.7%History
  2. FOLDAmicus Therapeutics, Inc.
    −0.80 pp0.8% → 0.0%History
  3. BIRKBirkenstock Holding plc
    −0.77 pp0.8% → 0.0%History
  4. GSGoldman Sachs Group Inc
    −0.64 pp3.8% → 3.1%History
  5. Makemytrip Limited Mauritius56087FAB0
    −0.60 pp0.6% → 0.0%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.56B
+$296.5M (+23.4%) vs. prior quarter
Positions
72
+5 vs. prior quarter
Top 10 concentration
80.1%
Top 10 as share of value
Turnover
9.4%
Q2 2026, one quarter
Average holding period
14.8 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $2.85B (Q4 2021)

Q1 2021: $1.43BQ2 2021: $1.48BQ3 2021: $1.27BQ4 2021: $2.85BQ1 2022: $2.27BQ2 2022: $1.52BQ3 2022: $1.22BQ4 2022: $1.68BQ1 2023: $1.70BQ2 2023: $1.71BQ3 2023: $1.67BQ4 2023: $1.66BQ1 2024: $1.07BQ2 2024: $1.06BQ3 2024: $1.16BQ4 2024: $1.11BQ1 2025: $1.05BQ2 2025: $716.0MQ3 2025: $900.8MQ4 2025: $1.05BQ1 2026: $1.27BQ2 2026: $1.56B
Q1 2021Q2 2026
13F filings of QVT Financial LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202672$1.56BROIVSPYECOvs. Q1 2026SEC
Q1 2026May 15, 202667$1.27BROIVECOGSvs. Q4 2025SEC
Q4 2025Feb 13, 202652$1.05BROIVALLTGSvs. Q3 2025SEC
Q3 2025Nov 14, 202546$900.8MROIVTRMLALLTvs. Q2 2025SEC
Q2 2025Aug 14, 202537$716.0MROIVGSALLTvs. Q1 2025SEC
Q1 2025May 15, 202537$1.05BROIVGSMPvs. Q4 2024SEC
Q4 2024Feb 14, 202534$1.11BROIVGSECOvs. Q3 2024SEC
Q3 2024Nov 14, 202435$1.16BROIVMPECOvs. Q2 2024SEC
Q2 2024Aug 14, 202433$1.06BROIVMPECOvs. Q1 2024SEC
Q1 2024May 15, 202433$1.07BROIVMPECOvs. Q4 2023SEC
Q4 2023Feb 14, 202431$1.66BROIVMPIMGNvs. Q3 2023SEC
Q3 2023Nov 14, 202336$1.67BROIVMPGSvs. Q2 2023SEC
Q2 2023Aug 14, 202338$1.71BROIVMPNXSTvs. Q1 2023SEC
Q1 2023May 15, 202344$1.70BROIVMPPalo Alto Networks Incvs. Q4 2022SEC
Q4 2022Feb 14, 202344$1.68BROIVMPNXSTvs. Q3 2022SEC
Q3 2022Nov 14, 202250$1.22BROIVMPNIO Inc.vs. Q2 2022SEC
Q2 2022Aug 15, 202258$1.52BROIVMPNIO Inc.vs. Q1 2022SEC
Q1 2022May 16, 202263$2.27BMPROIVWorkday, Inc.vs. Q4 2021SEC
Q4 2021Feb 14, 202255$2.85BROIVMPWorkday, Inc.vs. Q3 2021SEC
Q3 2021Nov 16, 202158$1.27BMPNIO Inc.Workday, Inc.vs. Q2 2021SEC
Q2 2021Aug 16, 202153$1.48BMPNIO Inc.Microchip Technology Incvs. Q1 2021SEC
Q1 2021May 17, 202150$1.43BMPNIO Inc.Microchip Technology Inc–SEC

13D and 13G filings

Companies where QVT Financial LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

4 companies, largest stake first.

Companies where QVT Financial LP owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
ALLTAllot Ltd.13D/A11.72%5.73M shares+1.27 ppfrom 10.45%Sep 3, 20244 filingsAug 26, 2026SEC
WHWKWhitehawk Therapeutics, Inc.13G9.37%2.31M sharesNewFeb 14, 20251 filingFeb 14, 2025SEC
TRMLTourmaline Bio, Inc.13G/A8.39%2.15M shares+2.65 ppfrom 5.74%May 15, 20252 filingsAug 14, 2025SEC
CMTLComtech Telecommunications Corp13G5.71%1.69M sharesNewMay 15, 20261 filingMay 15, 2026SEC

Latest filings

24 filings on file made by QVT Financial LP or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by QVT Financial LP
CompanyFiled (ET)FormStakeChangeEvent dateFiling
ALLTAllot Ltd.Aug 26, 20265:25 PM ET13D/A11.72%5.73M shares+1.27 ppfrom 10.45%Aug 24, 2026SEC
Real Asset Acquisition Corp.Class A Ordinary Shares, par value $0.0001 per shareAug 14, 20263:00 PM ET13G0.00%0 sharesNewBelow 5%Jun 30, 2026SEC
CMTLComtech Telecommunications CorpMay 15, 20265:11 PM ET13G5.71%1.69M sharesNewMar 31, 2026SEC
ALLTAllot Ltd.Nov 20, 20253:51 PM ET13D/A10.45%5.06M shares+1.40 ppfrom 9.05%Nov 18, 2025SEC
ROIVRoivant Sciences Ltd.Aug 14, 20254:39 PM ET13G/A4.30%29.4M shares−4.92 ppfrom 9.22%Below 5%Jun 30, 2025SEC
TRMLTourmaline Bio, Inc.Aug 14, 20254:00 PM ET13G/A8.39%2.15M shares+2.65 ppfrom 5.74%Jun 30, 2025SEC
TRMLTourmaline Bio, Inc.May 15, 20254:22 PM ET13G5.74%1.47M sharesNewMar 31, 2025SEC
ALLTAllot Ltd.Feb 28, 20258:02 PM ET13D/A9.05%3.56M shares–Feb 26, 2025SEC
WHWKWhitehawk Therapeutics, Inc.Feb 14, 20252:00 PM ET13G9.37%2.31M sharesNewDec 31, 2024SEC
ROIVRoivant Sciences Ltd.Feb 14, 20252:00 PM ET13G/A9.22%65.8M shares–Dec 31, 2024SEC
ALLTAllot Ltd.Sep 3, 202413D/AOld format–––SEC
ROIVRoivant Sciences Ltd.Mar 7, 202413G/AOld format–––SEC
ROIVRoivant Sciences Ltd.Feb 14, 202413G/AOld format–––SEC
MPMP Materials Corp.May 18, 202313D/AOld format–––SEC
MPMP Materials Corp.May 9, 202313D/AOld format–––SEC
ROIVRoivant Sciences Ltd.Feb 14, 202313G/AOld format–––SEC
MPMP Materials Corp.Sep 8, 202213D/AOld format–––SEC
MPMP Materials Corp.Jun 9, 202213D/AOld format–––SEC
MPMP Materials Corp.Mar 11, 202213D/AOld format–––SEC
Grindrod Shipping Holdings Ltd.Feb 14, 202213G/AOld format–––SEC